MGMT and neoplasm: Significant differences between non methylated and methylated MGMT tumors were observed in the total tumor/edema ratio ROI in both DL-models (DeepBraTumIA p = 0.02, Raidionics p < 0.01), and in the edema volumes extracted from DeepBraTumIA (p < 0.05) (Table 3).